---
title: "AET (Monase) - Complete Profile"
substance: "AET"
chemical_name: "Alpha-ethyltryptamine"
category: "Psychedelic"
legal_status: "Schedule I (US), Class A (UK)"
description: "The forgotten pharmaceutical psychedelic - a rare tryptamine with empathogenic properties and a complex history"
permalink: "/dyos-domain/substances/aet/"
---

<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/psychedelics/">Psychedelics</a> ‚Üí <span>AET (Monase)</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>üß¨ AET (Monase)</h1>
        <h2 class="chemical-name">Alpha-ethyltryptamine</h2>
          
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="AET" 
                data-category="Psychedelics" 
                data-chemical="Alpha-ethyltryptamine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Identifiers</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Common Names</h4>
              <span>AET</span> ‚Ä¢ <span>Œ±-ET</span> ‚Ä¢ <span>Alpha-ET</span> ‚Ä¢ <span>Etryptamine</span>
            </div>
            <div class="name-category">
              <h4>Pharmaceutical Names</h4>
              <span>Monase</span> ‚Ä¢ <span>Indopan</span> ‚Ä¢ <span>Alpha-ethyltryptamine HCl</span>
            </div>
            <div class="name-category">
              <h4>Research Codes</h4>
              <span>UP-3</span> ‚Ä¢ <span>Œ±-Ethyltryptamine</span> ‚Ä¢ <span>3-(2-Aminobutyl)indole</span>
            </div>
            <div class="name-category">
              <h4>Chemical Names</h4>
              <span>1-(1H-Indol-3-yl)butan-2-amine</span> ‚Ä¢ <span>3-(2-Aminobutyl)-1H-indole</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category psychedelic">Psychedelic/Empathogen</span>
          <span class="legal-status schedule-1">Schedule I</span>
          <span class="duration very-long">8-16 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/aet.jpg" alt="AET (Alpha-ethyltryptamine) crystalline powder and vintage Monase packaging" class="substance-photo">
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÅ‚ÇÇH‚ÇÅ‚ÇÜN‚ÇÇ</p>
            <p>MW: 188.27 g/mol</p>
            <p>Rare tryptamine</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification & Rarity</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure AET Characteristics</h4>
          <ul>
            <li><strong>Appearance:</strong> White to off-white crystalline powder</li>
            <li><strong>Texture:</strong> Fine crystalline solid, sometimes chunky</li>
            <li><strong>Odor:</strong> Faint amine-like smell</li>
            <li><strong>Taste:</strong> Bitter, chemical taste</li>
            <li><strong>Solubility:</strong> Soluble in water and alcohol</li>
            <li><strong>Melting point:</strong> ~178-182¬∞C (salt form)</li>
          </ul>
        </div>
        
        <div class="street-forms">
          <h4>Extremely Rare Substance</h4>
          <ul>
            <li><strong>Powder:</strong> Most common form when available</li>
            <li><strong>Capsules:</strong> Sometimes found in gelatin caps</li>
            <li><strong>Tablets:</strong> Very rare, occasionally pressed</li>
            <li><strong>Research chemical:</strong> Occasionally available from RC vendors</li>
            <li><strong>Pharmaceutical:</strong> Original Monase tablets (vintage, extremely rare)</li>
            <li><strong>Availability:</strong> Extremely limited, not commonly encountered</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Identification Challenges</h4>
          <p><strong>Rarity:</strong> Most "AET" is likely other substances or completely fake</p>
          <p><strong>Confusion:</strong> Often confused with AMT (Alpha-methyltryptamine)</p>
          <p><strong>Substitutes:</strong> 2C-x compounds or other psychedelics sold as AET</p>
          <p><strong>Testing essential:</strong> Due to rarity, always verify with reagent tests</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">20-40mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">40-80mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">80-120mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">120-160mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">160mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Historical & Research Dosing</h4>
        <ul>
          <li><strong>Pharmaceutical dose:</strong> 150-200mg daily as antidepressant (Monase)</li>
          <li><strong>Psychoactive threshold:</strong> 40-60mg for mild effects</li>
          <li><strong>Individual variation:</strong> Wide range of sensitivity reported</li>
          <li><strong>Long duration:</strong> Plan for 12+ hours, some report 16+ hours</li>
          <li><strong>Slow onset:</strong> Effects may take 2-3 hours to fully develop</li>
          <li><strong>No redosing:</strong> Extremely long duration makes redosing dangerous</li>
        </ul>
      </div>
      
      <p class="dosage-note"><strong>Critical Warning:</strong> Due to extreme rarity, most substances sold as AET are not genuine. Always test and start with minimal doses.</p>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile - Unique Tryptamine Experience</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Very Long Duration)</h4>
        <div class="timeline-item">
          <span class="time">T+0:30-2:00</span>
          <span class="effect">Slow onset - initial body load, mild stimulation</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+2:00-4:00</span>
          <span class="effect">Coming up - psychedelic effects begin, mood lift</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Peak - full psychedelic and empathogenic effects</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-12:00</span>
          <span class="effect">Plateau - continued effects, gradual decline</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+12:00-16:00</span>
          <span class="effect">Comedown - slow return to baseline, afterglow</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+16:00-24:00</span>
          <span class="effect">Residual effects - lingering stimulation, sleep difficulty</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category positive">
          <h4>‚úÖ Reported Positive Effects</h4>
          <ul>
            <li>Euphoria and mood enhancement</li>
            <li>Empathogenic feelings and emotional connection</li>
            <li>Mild visual distortions and color enhancement</li>
            <li>Increased energy and stimulation</li>
            <li>Enhanced music appreciation</li>
            <li>Sociability and openness</li>
            <li>Introspective thoughts and insights</li>
            <li>Body warmth and tactile enhancement</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Negative Effects & Risks</h4>
          <ul>
            <li>Hypertension (dangerous blood pressure increases)</li>
            <li>Cardiovascular strain and rapid heart rate</li>
            <li>Extreme duration causing fatigue</li>
            <li>Insomnia lasting 24+ hours</li>
            <li>Nausea and gastrointestinal distress</li>
            <li>Jaw clenching and muscle tension</li>
            <li>Anxiety and panic (especially with high doses)</li>
            <li>Vasoconstriction and circulation issues</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Mechanism</h3>
      <div class="pharma-details">
        <h4>Complex Tryptamine Pharmacology</h4>
        <p>AET is a substituted tryptamine that acts primarily as a releasing agent and reuptake inhibitor for serotonin, dopamine, and norepinephrine. Unlike classic tryptamine psychedelics that primarily work through 5-HT2A receptor agonism, AET's effects come from its ability to increase monoamine neurotransmitter levels, similar to MDMA but with additional tryptamine-like properties.</p>
        
        <h4>Receptor Activity Profile</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>Serotonin transporter (SERT)</strong></span>
            <span class="affinity">Moderate affinity</span>
            <span class="function">Primary empathogenic and mood effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Dopamine transporter (DAT)</strong></span>
            <span class="affinity">Moderate affinity</span>
            <span class="function">Stimulant effects, euphoria</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Norepinephrine transporter (NET)</strong></span>
            <span class="affinity">High affinity</span>
            <span class="function">Cardiovascular effects, alertness</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT2A receptor</strong></span>
            <span class="affinity">Weak agonist activity</span>
            <span class="function">Mild psychedelic effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>MAO inhibition</strong></span>
            <span class="affinity">Weak MAO-A inhibition</span>
            <span class="function">Contributes to long duration</span>
          </div>
        </div>

        <h4>Pharmacokinetics & Duration</h4>
        <div class="metabolism-details">
          <p><strong>Absorption:</strong> Oral bioavailability ~60-80%, slow absorption</p>
          <p><strong>Peak effects:</strong> 4-6 hours after ingestion</p>
          <p><strong>Half-life:</strong> Approximately 5-8 hours (estimated)</p>
          <p><strong>Duration factors:</strong> Active metabolites may contribute to long effects</p>
          <p><strong>Metabolism:</strong> Hepatic, likely via CYP enzymes</p>
          <p><strong>Elimination:</strong> Primarily urinary, slow clearance</p>
        </div>

        <h4>Why It's Different from Other Tryptamines</h4>
        <div class="neurotoxicity-info">
          <p><strong>Releasing agent activity:</strong> Unlike DMT/psilocybin, acts more like MDMA</p>
          <p><strong>Cardiovascular effects:</strong> Strong sympathomimetic activity increases heart rate/BP</p>
          <p><strong>Extended duration:</strong> Much longer than most tryptamines (8-16 hours vs 4-6)</p>
          <p><strong>Mixed pharmacology:</strong> Combines empathogenic and psychedelic properties</p>
          <p><strong>Stimulant component:</strong> More activating than classic psychedelics</p>
        </div>

        <h4>Cardiovascular Concerns</h4>
        <ul>
          <li><strong>Hypertension:</strong> Can cause dangerous blood pressure spikes</li>
          <li><strong>Tachycardia:</strong> Significant heart rate increases</li>
          <li><strong>Vasoconstriction:</strong> Reduced blood flow to extremities</li>
          <li><strong>Cardiac strain:</strong> Prolonged cardiovascular stress over 12+ hours</li>
          <li><strong>Individual risk:</strong> Particularly dangerous for those with heart conditions</li>
        </ul>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Safety Warnings</h4>
          <ul>
            <li><strong>Cardiovascular risk:</strong> Can cause dangerous hypertension</li>
            <li><strong>Extreme duration:</strong> 12-16+ hours of effects</li>
            <li><strong>Heart conditions:</strong> Potentially fatal for those with cardiac issues</li>
            <li><strong>Blood pressure:</strong> Monitor BP if possible during experience</li>
            <li><strong>Rarity factor:</strong> Most "AET" is likely other substances</li>
            <li><strong>No medical research:</strong> Modern safety data extremely limited</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Essential Precautions</h4>
          <ul>
            <li>Clear 24+ hours - effects are extremely long</li>
            <li>Blood pressure monitoring recommended</li>
            <li>Stay hydrated but avoid overhydration</li>
            <li>Have benzodiazepines available for emergency</li>
            <li>Never combine with stimulants or MAOIs</li>
            <li>Test substance thoroughly - AET is extremely rare</li>
            <li>Avoid if any cardiovascular conditions</li>
            <li>Have experienced sitter present</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Absolute Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Heart conditions, high blood pressure, arrhythmias, stroke history, or are taking MAOIs, SSRIs, or blood pressure medications. The cardiovascular risks are significant.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Extremely Dangerous</h4>
          <ul>
            <li><strong>MAOIs:</strong> Risk of hypertensive crisis and serotonin syndrome</li>
            <li><strong>Stimulants:</strong> Dangerous cardiovascular strain</li>
            <li><strong>Blood pressure meds:</strong> Unpredictable interactions</li>
            <li><strong>SSRIs/SNRIs:</strong> Serotonin syndrome risk</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>Other psychedelics:</strong> Unpredictable synergistic effects</li>
            <li><strong>Alcohol:</strong> Increased cardiovascular stress</li>
            <li><strong>Cannabis:</strong> May increase anxiety and paranoia</li>
            <li><strong>Tramadol:</strong> Serotonin syndrome risk</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Caution</h4>
          <ul>
            <li><strong>Caffeine:</strong> Additional cardiovascular strain</li>
            <li><strong>DXM:</strong> Serotonergic interactions</li>
            <li><strong>5-HTP:</strong> May increase serotonin syndrome risk</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Schedule I</strong> since 2003 - Illegal to manufacture, possess, or distribute. No accepted medical use.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Class A</strong> - Controlled under Misuse of Drugs Act. Possession and supply illegal.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá™üá∫ European Union</h4>
            <p><strong>Controlled</strong> - Scheduled in most EU member states following analog laws.</p>
          </div>
          <div class="jurisdiction">
            <h4>üåç International</h4>
            <p><strong>Widely controlled</strong> - Most countries have scheduled AET under psychoactive substance laws.</p>
          </div>
        </div>
        
        <div class="therapeutic-status">
          <h4>üè• Pharmaceutical History</h4>
          <p><strong>Monase (1960s):</strong> Marketed as an antidepressant by Upjohn Company but withdrawn due to cardiovascular side effects and limited efficacy. No current medical applications.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History - From Medicine to Underground</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1950s</span>
          <p>AET first synthesized and studied for antidepressant properties</p>
        </div>
        <div class="history-event">
          <span class="year">1961</span>
          <p>Upjohn Company releases Monase (AET) as prescription antidepressant</p>
        </div>
        <div class="history-event">
          <span class="year">1962-1964</span>
          <p>Reports of cardiovascular side effects and limited efficacy</p>
        </div>
        <div class="history-event">
          <span class="year">1965</span>
          <p>Monase withdrawn from market due to safety concerns</p>
        </div>
        <div class="history-event">
          <span class="year">1970s-1980s</span>
          <p>Occasional underground synthesis, very limited availability</p>
        </div>
        <div class="history-event">
          <span class="year">1990s</span>
          <p>Brief resurgence in research chemical markets</p>
        </div>
        <div class="history-event">
          <span class="year">2003</span>
          <p>DEA emergency schedules AET as Schedule I</p>
        </div>
        <div class="history-event">
          <span class="year">Present</span>
          <p>Extremely rare, occasionally appears in research chemical markets</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>The Forgotten Pharmaceutical</h4>
        <p>AET represents an interesting footnote in pharmaceutical history - a tryptamine antidepressant that failed in medical applications but found occasional use in underground psychedelic communities. Its extreme rarity makes it more of a historical curiosity than a significant recreational substance.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Limited Research & Knowledge Gaps</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>1960s Pharmaceutical Studies</h4>
          <p>Original research focused on antidepressant efficacy, showing modest benefits but significant cardiovascular side effects that led to market withdrawal.</p>
        </div>
        
        <div class="research-item">
          <h4>Cardiovascular Toxicity</h4>
          <p>Limited studies on AET's hypertensive effects and cardiovascular risks, mostly case reports from the pharmaceutical era.</p>
        </div>
        
        <div class="research-item">
          <h4>Pharmacology Studies</h4>
          <p>Basic receptor binding studies showing its activity as a monoamine releasing agent, but detailed pharmacokinetics remain poorly understood.</p>
        </div>
        
        <div class="research-item">
          <h4>Modern Safety Data</h4>
          <p>Virtually no modern research on AET's safety profile, recreational use patterns, or long-term effects.</p>
        </div>
        
        <div class="research-item">
          <h4>Analytical Chemistry</h4>
          <p>Development of detection methods for forensic and clinical purposes, important given its rarity and potential for misidentification.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Testing & Identification</h4>
        <ul>
          <li><a href="https://bunkpolice.com/">The Bunk Police</a> - Test kits (though AET detection limited)</li>
          <li><a href="https://drugsdata.org/">DrugsData.org</a> - Professional lab testing</li>
          <li><strong>Note:</strong> Most "AET" is likely other substances</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Medical Information</h4>
        <ul>
          <li><a href="https://pubmed.ncbi.nlm.nih.gov/">PubMed</a> - Historical pharmaceutical research</li>
          <li><strong>Emergency:</strong> Seek medical attention for chest pain/hypertension</li>
          <li><strong>Blood pressure:</strong> Monitor if possible during experience</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Community Resources</h4>
        <ul>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - Limited user reports</li>
          <li><a href="https://bluelight.org/">Bluelight</a> - Harm reduction forum</li>
          <li><strong>Caution:</strong> Very limited community knowledge due to rarity</li>
        </ul>
      </div>
    </div>
  </div>

</div>